Skip to Main Content

Patient Insights Shape Lupus Guidelines for Better Care

Publication Title: A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development

Summary

Question
This study examined how the experiences, perspectives, and priorities of patients with systemic lupus erythematosus (SLE) and lupus nephritis (LN)—a severe kidney-related complication of SLE—can inform clinical guidelines for screening, treatment, and monitoring. The authors aimed to incorporate patient-centered approaches into the development of the American College of Rheumatology (ACR) 2024 LN and 2025 SLE guidelines.
Why it Matters
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can cause significant organ damage and life-altering symptoms, including lupus nephritis (LN), a severe manifestation affecting kidney function. Current treatment guidelines often fail to fully account for patients' real-world experiences and preferences, leading to gaps between clinical recommendations and patient needs. By integrating patient perspectives, this research aims to create more personalized, practical, and effective guidelines, improving quality of life, treatment adherence, and long-term outcomes for individuals living with SLE and LN.
Methods
The researchers conducted a qualitative study using feedback from two patient panels, which included 19 individuals with SLE and/or LN. The panels discussed their priorities, values, and treatment experiences. Key themes from these discussions were presented to voting panels, which included both healthcare providers and patient representatives. The patient input was actively integrated into the guideline development process to ensure alignment with real-world concerns.
Key Findings

Thematic analysis revealed three major domains: (1) Treatment and monitoring—patients emphasized minimizing medication side effects, improving daily function, avoiding disease flares, and preventing organ damage; (2) Clinical communication—patients highlighted the importance of shared decision making, compassionate care, and addressing imbalances in the clinician-patient relationship; (3) Transparency and information sharing—patients stressed the need for clearer communication about clinical trials, medical costs, and insurance coverage. Patient input influenced key guideline decisions, such as balancing treatment efficacy with side effects and addressing fertility concerns tied to certain medications.

Implications

Incorporating patient perspectives into clinical guidelines enhances their relevance and applicability. This approach aligns recommendations with patients' lived experiences, supporting shared decision-making, fostering trust, and improving adherence to treatment. For clinicians, these findings highlight the importance of tailoring care to individual values, life phases, and long-term goals. For patients, the updated guidelines aim to support a more holistic and empathetic approach to managing SLE and LN.

Next Steps

The authors suggest continuing to integrate a broader range of patient voices into guideline development processes for other chronic diseases. They recommend further research on perspectives that have received less attention in guideline development, such as those of patients without LN or those navigating different healthcare systems globally, to make guidelines more inclusive and comprehensive.

Funding Information
This research was supported by the American College of Rheumatology and the Lupus Foundation of America. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Yale University also provided funding and support for this research.

Full Citation

Garg S, Hartel I, Sammaritano L, Askanase A, Bermas B, Dall'Era M, Duarte‐García A, Werth V, Rovin B, Mustafa R, Turner A, Williams B, Ung B, Bhavsar H, Gore‐Massy M, Pulido N, Guerrero N, Smith N, Machua W, Hiraki L, Son M. A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development. Arthritis Care & Research 2025, 78: 925-935. PMID: 41182325, PMCID: PMC13313109, DOI: 10.1002/acr.25693.
This AI-assisted summary has been reviewed and approved by at least one of the study's authors to ensure it accurately reflects the research.

Authors

  • Mary Beth Son

    Last Author
    Other Institution

Research Themes

Get Involved With This Research

Media Contact

For media inquiries, please contact us.